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Objective To evaluate Infecton scintigraphy, with technetium-99m-radiolabeled cipro-
floxacin, as a means to detect bone infection, in comparison with other conventional
scintigraphic and radiologic methods.
Methods Forty-five patients with known or suspected bone infection underwent 50
scans with Infecton. Almost all were also subjected to a three-phase 99mTc-methylene
diphosphonate bone scan and most of them to a 99mTc-human polyclonal immunoglo-
bulin scan as well as to a gallium-67-citrate scan, plus computerized tomography or
magnetic resonance imaging or both. Clinical laboratory criteria for the presence of
osteomyelitis were based on the definitions of the Centers for Disease Control and
Prevention.
Results Staphylococcus aureus and Pseudomonas aeruginosa were the most frequently
isolated pathogens. Based on the CDC clinical laboratory criteria as well as on conven-
tional scan results, Infecton was characterized in 35 studies as ‘true positive’, in eight as
‘true negative’, in two as ‘false positive’, in one as ‘false negative’, and in four as
‘indeterminate’. The sensitivity and specificity of Infecton scintigraphy were found to
be 97.2% and 80%, respectively, with positive and negative predictive values of 94.6% and
88.9%.
Conclusions It is concluded that Infecton is a very sensitive and quite specific marker of
bone infection, but care must be taken in cases of excessive new bone formation and
primary bone tumors, where false-positive results may be obtained.
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I N T R O D U C T I O N
The currently available nuclear imaging techni-
ques for diagnosing bone infection, i.e. IIIIn- or
99mTc-labeled autologous leukocytes, 99mTc-labeled
antigranulocyte antibodies, 99mTc-human poly-
clonal immunoglobulin (HIG), three-phase
99mTc-methylene diphosphonate bone scan (MDP)
and 67Ga-citrate scan (67Ga), cannot distinguish
between bacterial infection and non-infectious
inflammation [1–8]. A new radiopharmaceutical,
99mTc-labeled ciprofloxacin, otherwise called
Infecton, has been developed to overcome this
difficulty [9].
All nuclear medicine modalities use one or more
of the stages of the functional cataract of inflam-
mation or infection, which are activated as a part of
the defense mechanisms of the host. Infecton,
however, differs because it is based on the use
of ciprofloxacin, which binds to a wide range of
Gram-positive and Gram-negative bacteria via the
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DNA gyrase of the microorganisms [10]. In vitro
studies and animal experiments have shown that
Infecton binds only to sites of active bacterial
infection and not to dead bacteria or sites of sterile
inflammation [11]. In a population of 102 patients
with a variety of infections undergoing an Infecton
scan, Britton et al. reported an overall sensitivity
and specificity of the method of 83% and 91%,
respectively [11].
The aim of this study was to evaluate Infecton
scintigraphy as a means to detect bone infection—
in comparison with other conventional scinti-
graphic and radiologic methods—in patients with
chronic osteomyelitis according to the Centers for
Disease Control and Prevention (CDC) clinical
laboratory criteria [12].
P A T I E N T S A N D M E T H O D S
Between December 1995 and February 2000, 45
patients with proven or suspected bone infection
entered the study, which was approved by the
local Ethics Committees of the participating hos-
pitals after patients had given their informed con-
sent. They were 22 men and 23 women, ranging in
age from seven to 84 years (mean age 47.5 years).
To assess the presence or absence of infection in
the studied population, the following methods
were used.
Scintigraphy
Every patient underwent an Infecton scan 1 h and
4 h after injection of the radiolabeled ciprofloxacin,
and most of them underwent an MDP scan to
assess bone metabolism in the involved area. Sev-
eral patients also underwent HIG and 67Ga scans.
MDP, HIG and 67Ga scans were performed at 4 h, 4
and 24 h, and 6 and 24 h, respectively. Some parti-
cipating patients did not undergo all scans,
because they were referrals from other hospitals
to perform only the Infecton scan, or because of
lack of time, since they were referred just prior to
already scheduled orthopedic surgery.
Infecton, the new imaging agent, was supplied
by Professor Britton and Mr Solanki (Saint Bartho-
lomew’s Hospital, London, UK). This project was
carried out with the support of the International
Atomic Energy Agency (IAEA) Coordinated
Research Project on In Vivo Imaging for Infec-
tion/Inflammation (Research Contract no. 9060).
99mTc-Infecton was prepared by mixing 2 mg of
ciprofloxacin, 500 mg of stannous tartrate, and
400 MBq of freshly eluted sodium pertechnetate.
The mixture was left standing at room tempera-
ture for 15 min. This radiopharmaceutical prepara-
tion had 98% (SD 3%) radiochemical purity and
was radiochemically stable over 8 h [9]. Between
370 and 400 MBq of Infecton was injected into each
patient intravenously over 40 s. Anterior and pos-
terior whole body static images were acquired at
approximately 1 and 4 h after injection. Both pla-
nar and tomographic views (4 h) were also
obtained. Infecton scintigraphic evaluation was
carried out blindly by two independent experi-
enced nuclear medicine physicians. The grading
used was as follows: negative (–), positive (þ) and
equivocal (þ/–). The last definition was used
when the scan was mildly positive.
Radiology
All patients underwent conventional radiology,
and almost all of them underwent a CT or an
MRI scan, or both.
Clinical laboratory assessment
The clinico-laboratory criteria applied for asses-
sing osteomyelitis as ‘definite’ were based on the
CDC definitions [12]. Osteomyelitis was character-
ized as ‘definite’ when any one of the following
criteria was present: (1) a microorganism consid-
ered as pathogenic was cultured from a bone
specimen derived by open or closed bone biopsy;
(2) evidence of osteomyelitis was seen during
surgery or by histopathologic examination; (3)
two of the following criteria were present, with
no other recognized cause—fever (>38 8C), loca-
lized swelling, tenderness, heat or drainage at
suspected site of infection and any one of the
following: (a) organism isolated from blood cul-
ture; (b) positive antigen test in blood; (c) radio-
graphic evidence of infection (i.e. conventional
radiology, CT and/or MRI). Osteomyelitis was
considered as ‘probable’ when the CDC criteria
for ‘definite’ osteomyelitis were only partially met,
but the attending physician considered the patient
to be infected. Tuberculosis was verified only by
positive culture of bone biopsy specimens, and
brucella osteomyelitis by positive blood agglutina-
tion test (titers 1/320).
According to the IAEA Coordinated Research
Project Protocol, the applied criteria for scinti-
graphic assessment were the following. When
Infecton results were in agreement with MDP,
HIG and 67Ga results on the one hand, and with
102 Clinical Microbiology and Infection, Volume 9 Number 2, February 2003
 2003 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 9, 101–109
clinical laboratory assessment on the other, results
were characterized as ‘concordant correct’, either
‘true positive’ or ‘true negative’. When the above-
mentioned results were in disagreement, or HIG
and 67Ga results were not available, MDP showing
only increased bone metabolism, then the judg-
ment was based on clinical, microbiological and
imaging data, always complying with the CDC
criteria [12] as follows: (1) if patients were on
antibiotics and there was evidence of efficacy of
antibiotics on clinical, microbiological and ima-
ging findings, while Infecton scan was negative
after 4–6 weeks of treatment, then the study was
classified as ‘true negative’; (2) if there was evi-
dence of persistent infection on clinical laboratory
grounds and the Infecton scan was positive, then
the study was classified as ‘true positive’; (3) if the
Infecton result rating was equivocal, in the setting
of a bone infection characterized as ‘definite’ by
CDC criteria, then the final Infecton scan interpre-
tation was ‘true positive’; and (4) if there was an
equivocal Infecton rating in the setting of a ‘prob-
able’ infection according to CDC criteria, the final
Infecton scan interpretation was characterized as
‘indeterminate’. This group of indeterminate
Infecton studies was clarified in the context of
clinical follow-up, but this was not included in
the statistical evaluation of the new method.
Susceptibilities of the isolated microorganisms
to ciprofloxacin were determined by the disk dif-
fusion method according to the NCCLS criteria
[13].
R E S U L T S
Forty-five patients underwent 50 Infecton scans,
since studies were repeated at the follow-up in five
patients (Table 1, nos. 3, 5, 6, 19 and 20). No
adverse reactions were observed following Infec-
ton administration. According to the CDC criteria
Table 1 Infection sites, predisposing conditions, results of three-phase MDP, HIG, 67Ga and Infecton scans, isolated
microorganisms and their susceptibilities to ciprofloxacin, the diagnosis of ‘definite’ or ‘probable’ osteomyelitis on the basis
of CDC criteria and ‘true-positive/negative’, ‘false-positive/negative’ and ‘indeterminate’ scores for 45 patients with
proven or suspected bone infection
No.
Infection site/
predisposing
condition
Three-phase
MDP
scan
HIG
scan
67Ga
scan
Infecton
scan
CDC
definition
Infecton
result
1 Thigh/POS 3þ ND ND þ
plus
STIþ
D(2) TP
2 Femur/POS 3þ þ ND þ D(1) TP
3a Knee/POS 3þ þ
plus
STIþ
þ
plus
STIþ
þ
plus
STIþ
D(1) TP
3b Knee/POS 3þ ND ND þ/ D(1) TP
4 Femur/POS 3þ ND ND þ
plus
STIþ
D(2) TP
5a Spine
(L1–L2)
þ ND ND þ D(3b) TP
5b Spine þ ND ND þ/ D(3b) TP
6a Tibia 3þ þ þ þ D(3c) TP
6b Tibia/POS ND ND ND þ D(3c) TP
7 THR 3þ þ þ þ D(2) TP
8 Femur 3þ þ ND þ D(3c) TP
9 Calcaneous/POS 3þ þ þ þ D(3c) TP
10 TKR 3þ þ ND þ D(3c) TP
11 Tibia/POS 3þ ND ND þ D(3c) TP
12 Tibia/POS 3þ ND þ þ D(1) TP
13 Mandible 3þ ND þ þ D(2) TP
14 Tarsus/PT 3þ þ þ þ D(2) TP
15 Sacroiliitis þ þ þ þ D(2) TP
16 TKR 3þ ND þ þ D(2) TP
17 Spine (L1–L2) 3þ ND ND þ D(3b) TP
18 Tibia/POS 3þ  ND þ D(2) TP
19a Knee/POS 3þ þ þ þ D(2) TP
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[12], of 45 patients studied, 34 had ‘definite’ osteo-
myelitis, six had ‘probable’ osteomyelitis, and five
were not infected. The most frequently isolated
microorganisms from patients with ‘definite’
osteomyelitis were Staphylococcus aureus (12) and
Pseudomonas aeruginosa (6). In the remaining
patients, Staphylococcus epidermidis (3), other coa-
gulase-negative staphylococci (CNS) (3), Brucella
melitensis (3), Enterococcus faecalis (3), Stenotropho-
monas maltophilia (1), Proteus vulgaris (1) and Myco-
bacterium tuberculosis (1) were isolated. With the
exception of one CNS strain (Table 1, no. 23), all
isolates were susceptible to ciprofloxacin.
Details of all scintigraphic results are given in
Table 1. It should be pointed out that patients no.
35 and no. 42 were given antibiotics for over
12 months, and the performed bone biopsies were
not indicative of active infection. On the other
hand, patients nos. 36, 37 and 41 with ‘definite’
osteomyelitis, as well as patient no. 38 with
‘probable’ osteomyelitis ended up with ‘true-nega-
tive’ results following prolonged antibiotic treat-
Table 1 continued
No.
Infection site/
predisposing
condition
Three-phase
MDP
scan
HIG
scan
67Ga
scan
Infecton
scan
CDC
definition
Infecton
result
19b Knee/POS 3þ ND þ þ D(2) TP
20a TKR 3þ þ þ þ/ D(2) TP
20b TKR ND ND þ þ D(2) TP
21 Tibia 3þ þ/ þ þ D(2) TP
22 THR ND ND þ þ/ P IND
23 Foot 3þ þ ND þ D(3c) TP
24 Spine (L2–L4) 3þ þ ND þ D(2) TP
25 THR 3þ þ ND þ D(2) TP
26 Foot/PT 3þ þ
plus
STIþ
ND þ
plus
STIþ
D(3c) TP
27 Sternum/CBS 3þ ND þ
þ
plus
þ
þ
plus
D(3c) TP
28 Foot/PT 3þ ND STIþ STIþ D(1) TP
29 THR þ ND þ þ/ P IND
30 HIP þ þ ND þ/ P IND
31 Tibia/POS 3þ þ ND þ D(2) TP
32 Spine ND ND þ þ D(3c) TP
33 THR 3þ ND þ
plus
STIþ
þ/
plus STIþ
P IND
34 Tibia/PT 3þ ND ND þ D(3c) TP
35 THR ND    D(2) TN
36 Spine (L2–L3) þ  þ  D(3c) TN
Hip
37 Humerus  ND ND  D(1) TN
38 Foot  ND ND  P TN
39 Spine (L1–L3) ND ND   NI TN
40 Spine (L1–L2) ND ND   NI TN
41 Foot/POS 3þ  ND  D(3c) TN
42 Femur/POS þ  þ  NI TN
43 Foot/Hip ND þ
plus
STIþ
þ þ
plus
STIþ
P FP
44 THR þ ND ND þ NI FP
45 Spine (L2–L3) þ ND ND  D(2) FN
a, before infection; b, at the follow-up period; POS, post orthopedic surgery; THR, total hip replacement; TKR, total knee
replacement; PT, post-trauma; CBS, coronary bypass surgery; STI, soft tissue infection; ND, not done; S, sensitive; R,
resistant; NI, infection not present; D, definite osteomyelitis; 1, 2, 3a, 3b, 3c, CDC criteria for defining ‘definite’
osteomyelitis; P, ‘probable’ osteomyelitis; TP, ‘true positive’; TN, ‘true negative’; FP, ‘false positive’; FN, ‘false negative’;
IND, ‘indeterminate’; 3þ, all three phases positive; þ, only third phase positive; CNS, coagulase negative staphylococcus.
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ment. Two ‘false-positive’ results were recorded.
The first concerned patient no. 43 with Ewing’s
sarcoma of the left third metatarsal, who presented
with increased uptake of Infecton even after an
additionally acquired view at 24 h. The second
case refers to patient no. 44 with excessive new
bone formation that developed around a loose hip
prosthesis. Both patients also had increased
uptake of all infection-seeking radiopharmaceuti-
cals used in this study. The only ‘false-negative’
Infecton investigation concerned patient no. 45,
who was suffering from Staphylococcus aureus
osteomyelitis verified only on surgical biopsy,
whereas in the preceding closed biopsy no infect-
ing microorganism had been isolated, although an
MRI scan had been positive, showing vertebal
osteomyelitis and a paraspinal abscess.
In order to estimate Infecton sensitivity, studies
on patients with ‘definite’ osteomyelitis by CDC
criteria, i.e. ‘true-positive’ and ‘false-negative’ stu-
dies, were included, while patients with ‘probable’
osteomyelitis were excluded (Table 2). On the
other hand, to estimate specificity, studies of
patients with ‘definite’ osteomyelitis cured after
successful treatment as well as studies of patients
who were not infected, i.e. ‘true negative’ and
‘false positive’, were included (Table 2). In total,
there were 35 ‘true-positive’, eight ‘true-negative’
and two ‘false-positive’ studies, and one ‘false-
negative’ study. On processing these data, a sen-
sitivity of 97.2% and a specificity of 80% were
estimated. Results obtained with three-phase
MDP were as follows: 29 studies were ‘true posi-
tive’, i.e. all three phases were positive; five studies
were characterized as ‘true negative’, i.e. two stu-
dies were negative, while three studies were posi-
tive only on the third phase; four studies were
characterized as ‘false negative’, i.e. in the pre-
sence of infection only the third phase was posi-
tive; and one study was ‘false positive’ (Table 1,
no. 43 with Ewing’s sarcoma). The calculated sen-
sitivity of three-phase MDP was 87.9%, and the
specificity was 83.3%. HIG and 67GA were used
only in 23 and 24 studies, respectively, so the
Table 2 Sensitivity, specificity, and positive and negative predictive accuracy of the nuclear imaging methods used to
detect bone infection
Statistical valuea
99mTc-MDP scan
(39 studies)
99mTc-HIG scan
(23 studies)
67Ga-citrate scan
(23 studies)
Infecton scan
(46 studies)
Sensitivity 87.9% 94.4% 100.0% 97.2%
Specificity 83.3% 80.0% 50.0% 80.0%
Positive predictive accuracy 96.7% 94.4% 85.0% 94.6%
Negative predictive accuracy 55.6% 80.0% 100.0% 88.9%
aAccording to definite CDC criteria for osteomyelitis [12].
Figure 1 Patient no. 6, with a history of a soft tissue infection of her left tibia and a short course of antibiotics, presented to
the Infectious Diseases Outpatient Clinic with a tibial X-ray (A), consistent with an osteoid osteoma or a chronic osteitis of
the sclerosing type. All scans carried out, including HIG, were positive and had exactly the same pattern of uptake. (B)
MDP. (C) HIG 24 h. (D) 67Ga 48 h. (E) Infecton 4 h. An MRI (F) scan signaling the presence of osteomyelitis and excluding
the presence of neoplasia supported the scintigraphic results.
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Figure 2 Patient no. 42, complaining
of pain after removal of a metallic
plate for a left femoral fracture, had
no clinical evidence of infection. X-
rays (A) and CT (B) were not
indicative of infection. 67Ga scan
(C) showed uptake in the callous
area of the fracture, as did the MDP
scan (not shown). However, HIG
and Infecton scans (E) were nega-
tive, excluding infection.
Figure 3 Patient no. 20 (aþ b) with a
knee replacement (X-ray) (A) com-
plaining of persistent pain had a
positive HIG scan (B) and an equi-
vocal Infecton 4-h scan (C). The
latter scan is contrast enhanced to
show the diffusely increased uptake
around the femoral component of
the arthroplasty. He was treated
only with anti-inflammatory drugs,
because he was considered to be
suffering from a sterile inflamma-
tory response to the implant. Two
months later, he developed a fistula,
and a new Infecton scan (D) showed
increased uptake around the whole
arthroplasty, confirming infection.
 2003 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 9, 101–109
106 Clinical Microbiology and Infection, Volume 9 Number 2, February 2003
results obtained were not strictly comparable with
those of Infecton. However, a remarkably low
specificity of 50% was estimated for 67Ga (Table 2).
Representative cases of patients in whom infecton
scintigraphy in comparison to other conventional
scintigraphic and radiological treatments, were
performed, are shown in Figs 1–3.
D I S C U S S I O N
The currently available infection-seeking radio-
pharmaceuticals cannot distinguish between ster-
ile inflammation and bone infection. Scintigraphic
agents such as HIG, IIIIn- or 99mTc-labeled anti-
granulocyte antibodies and 67Ga are taken up by
various mechanisms equally in areas of non-sterile
and sterile inflammation [1–8]. However, there is
growing evidence that, by its specific binding to
infecting microorganisms, Infecton has the ability
to recognize only infection and not sterile inflam-
mation. The latter observation is based on radio-
labeled ciprofloxacin uptake by the DNA gyrase of
the pathogenic microorganisms [10], offering the
possibility of detecting the presence of live micro-
organisms in the infected area. This is of potential
clinical significance not only for correct diagnosis
but also for the determination of the appropriate
duration of antimicrobial treatment, particularly in
cases of chronic bone infection, where the length of
therapy is prolonged. It has been observed that
even in the case of in vitro resistance to ciproflox-
acin, Infecton is still taken up by the infected area,
since, in most cases, DNA gyrase A or topoisome-
rase IV mutations are involved [14], which do not
interfere with Infecton uptake by bacteria [15]. In
contrast, resistant bacteria whose cell membranes
are impermeable to ciprofloxacin fail to bind Infec-
ton, so infections caused by such microorganisms
should not be detected by this novel radiophar-
maceutical [14]. However, this statement is theo-
retical and deserves careful prospective and
microbiologically confirmed studies. On the other
hand, although neutrophils and activated macro-
phages can take up ciprofloxacin [16], there is no
evidence that the latter effect plays any significant
role in Infecton imaging, since: (1) in animal mod-
els Infecton is accumulated only by bacterial and
not by sterile abscesses; (2) Infecton imaging is
negative in Crohn’s disease and ulcerative colitis;
and (3) human white blood cells in vitro exhibit
either no uptake or insignificant uptake of Infecton
[14].
It should be pointed out that Infecton, in con-
trast to radiolabeled leukocytes, is not taken up
by the bone marrow [17], but, due to its small
size, can penetrate easily into infected areas. The
latter is of significance, particularly in cases
of infected arthroplasties, whenever painful
orthopedic implants attributed to cement dis-
lodging have to be distinguished from real infec-
tion.
The aim of this study was to evaluate Infecton as
a radiopharmaceutical for the detection of bone
infection. The results obtained suggest remarkable
sensitivity and quite satisfactory specificity in
detecting bone infection. There were two ‘false-
positive’ results (Table 1, no. 43 and no. 44) and
one ‘false-negative’ result (Table 1, no. 45). Patient
no. 43 was proven by biopsy to suffer from
Ewing’s sarcoma of the third metatarsal. Probably,
the prolonged stasis of the radiopharmaceutical
within a highly vascularized tumor was respon-
sible for the false-positive results. Patient no. 44
had extensive new bone formation, which exhib-
ited high Infecton uptake. A possible explanation
could be that ciprofloxacin concentrates in bone
not only in cases of infection, but also whenever
there is excessive bone formation [16,18], an event
also observed with HIG and 67Ga. In addition,
other investigators have observed Infecton uptake
in epiphyseal plates and areas of high osteoblastic
activity (personal communication with Britton and
Bhatnagar in the framework of the Coordinated
Research Program on Infecton). There is, however,
no obvious explanation for the false-negative
result obtained in the case of patient no. 45.
In 31 of 32 patients with ‘definite’ osteomyelitis,
the isolated microorganisms were susceptible to
ciprofloxacin, and the Infecton study proved to be
‘true positive’ in 29 patients and ‘true negative’ in
the remaining two patients (Table 1, no. 36 and no.
37), in whom Infecton was given after at least 6
months of successful antimicrobial therapy. In the
latter cases, the isolated strains represented the
initial pathogens expected to have been eradi-
cated, rendering the Infecton result ‘true negative’.
Finally, in one patient with a ‘true-positive’ Infec-
ton (Table 1, no. 23) result, a CNS strain resistant to
ciprofloxacin had been isolated. As already men-
tioned, this unexpected finding could be explained
by the fact that bacteria resistant to ciprofloxacin
can still take up Infecton when resistance is attrib-
uted to DNA gyrase and topoisomerase IV altera-
tions [15].
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The sensitivity and specificity values in the
present study were 97.2% and 80.0%, respectively
(Table 2), while those reported by Britton et al.
in bone infection were 89% and 91% [11]. Prob-
ably, the higher sensitivity obtained in this
series resulted from the inclusion of a higher
number of patients with proven ‘true-positive’
results.
In conclusion, from the reported results, it is
evident that Infecton is a true bone infection mar-
ker with a high sensitivity and a satisfactory spe-
cificity, but which should, however, be carefully
evaluated in the presence of extensive new bone
formation. Infecton is not taken up by areas of non-
infectious inflammation, as is the case with MDP,
HIG, 67Ga and leukocytes radiolabeled with IIIIn or
99mTc. When compared, in particular, with white
cell imaging, the Infecton scan is simpler, cheaper,
safer with regard to handling of the radiopharma-
ceutical, and not dependent on the patient’s white
cell count, a factor permitting imaging in neutro-
penics. Infecton seems to be of particular use in
differentiating post-orthopedic implant infections,
where MDP and 67Ga scans are not helpful due to
bone remodeling, while CT and MRI scans pose
significant technical difficulties. On the other
hand, Infecton seems to become negative upon
subsidence of bone infection. Therefore, in the
presence of clinical and laboratory cure of osteo-
myelitis and before discontinuation of antibiotics,
it is suggested that the Infecton scan be repeated in
order to clarify the absence or persistence of active
infection and the necessity for further therapeutic
intervention.
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